Optimal treatment for post-MI heart failure in rats: dapagliflozin first, adding sacubitril-valsartan 2 weeks later

BACKGROUND: Based on previous research, both dapagliflozin (DAPA) and sacubitril-valsartan (S/V) improve the prognosis of patients with heart failure (HF). Our study aims to investigate whether the early initiation of DAPA or the combination of DAPA with S/V in different orders would exert a greater...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Wenqi, Yang, Xiaoyu, Zhang, Qing, Bi, Shuli, Yao, Zhuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296765/
https://www.ncbi.nlm.nih.gov/pubmed/37383701
http://dx.doi.org/10.3389/fcvm.2023.1181473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296765/
https://www.ncbi.nlm.nih.gov/pubmed/37383701
http://dx.doi.org/10.3389/fcvm.2023.1181473

Ejemplares similares